Neuropace, Inc. NPCE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$6.69M-145% | -$2.73M+21.9% | -$3.5M+59.6% | -$8.65M-31.3% | -$6.59M-25.5% | ||
| $60K-25.0% | $80K-20.0% | $100K0.0% | $100K+104% | $49K+2.1% | ||
| $2.28M-12.6% | $2.61M-0.8% | $2.63M-18.6% | $3.23M+22.9% | $2.63M+0.9% | ||
| $68K+7.9% | $63K-10.0% | $70K+27.3% | $55K+12.2% | $49K0.0% | ||
| $0+100% | -$12K— | —— | —— | -$2K— | ||
| $108K— | —— | $1.38M— | —— | $2.59M+101% | ||
| -$125K— | —— | $1.84M-34.8% | $2.82M+1,058% | $243K-82.0% | ||
| $2.2M+192% | -$2.39M-4,869% | -$48K-107% | $737K-23.7% | $966K+25.0% | ||
| -$4M-491% | $1.02M-61.4% | $2.65M+19.7% | $2.21M+195% | -$2.33M-721% | ||
| $77K+110% | -$809K— | —— | -$521K-247% | -$150K— | ||
| -$15K+97.0% | -$507K-956% | -$48K-382% | $17K-86.3% | $124K+164% | ||
| $453K+2.5% | $442K+2.1% | $433K+2.6% | $422K+2.2% | $413K+2.5% | ||
| -$513K-6.9% | -$480K-2.3% | -$469K-1.7% | -$461K-2.4% | -$450K-7.1% | ||
| -$5.9M— | $0+100% | -$1.94M+6.8% | -$2.09M+72.1% | -$7.48M-56.0% | ||
| $117K+20.6% | $97K+223% | $30K-82.1% | $168K+354% | $37K-5.1% | ||
| -$117K-20.6% | -$97K-223% | -$30K+82.1% | -$168K-354% | -$37K-102% | ||
| $0— | —— | —— | —— | $49.55M— | ||
| $10K-98.6% | $723K+72,200% | $1K-99.9% | $766K+99.0% | $385K-35.3% | ||
| $176K+100% | $88K+66.0% | $53K-69.5% | $174K-23.7% | $228K+148% | ||
| -$166K-126% | $635K— | —— | —— | $21.11M+2,389% | ||
| -$6.18M-692% | $1.04M— | —— | —— | $13.59M+784% | ||
| $1.39M-5.0% | $1.46M+0.1% | $1.46M+5.3% | $1.39M-26.7% | $1.89M-2.2% | ||
| $68K+7.9% | $63K-10.0% | $70K+27.3% | $55K+12.2% | $49K0.0% | ||
| $60K-25.0% | $80K-20.0% | $100K0.0% | $100K+104% | $49K+2.1% | ||
| -$165K— | —— | $82K— | —— | -$82K— | ||
| $77K+2.7% | $75K+2.7% | $73K-58.8% | $177K-16.9% | $213K+0.9% | ||
| -$513K-6.9% | -$480K-2.3% | -$469K-1.7% | -$461K-2.4% | -$450K-7.1% | ||
| $77K+110% | -$809K— | —— | -$521K-247% | -$150K— | ||
| $76K+300% | $19K-59.6% | $47K-4.1% | $49K+11.4% | $44K-20.0% | ||
| $453K+2.5% | $442K+2.1% | $433K+2.6% | $422K+2.2% | $413K+2.5% | ||
| —— | —— | —— | —— | —— | ||
| $10K-98.6% | $723K+72,200% | $1K-99.9% | $766K+99.0% | $385K-35.3% | ||
| $114K+850% | $12K— | —— | —— | $141K+642% | ||
| $0— | —— | —— | —— | $277K+2,418% | ||
| $0— | —— | —— | —— | $611K— | ||
| -$15K+97.0% | -$507K-956% | -$48K-382% | $17K-86.3% | $124K+164% | ||
| -$513K-6.9% | -$480K-2.3% | -$469K-1.7% | -$461K-2.4% | -$450K-7.1% | ||
| -$6.02M— | $0+100% | -$1.97M+12.4% | -$2.25M+70.0% | -$7.52M-55.5% | ||
| -$6.02M— | $0+100% | -$1.97M+12.4% | -$2.25M+70.0% | -$7.52M-55.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Neuropace, Inc. generate?
- Neuropace, Inc. (NPCE) generated -$9.9M in operating cash flow over the trailing twelve months.
- What is Neuropace, Inc.'s free cash flow?
- After $412.0K of capital expenditures, Neuropace, Inc.'s free cash flow was -$10.2M over the trailing twelve months, up 43.5% year over year.
- Where does Neuropace, Inc.'s cash flow data come from?
- Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
